Health X Platform Statistics
Total Valuation
BOM:533259 has a market cap or net worth of INR 9.57 billion. The enterprise value is 10.77 billion.
| Market Cap | 9.57B |
| Enterprise Value | 10.77B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 31.81M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 39.22% |
| Owned by Institutions (%) | 1.15% |
| Float | 6.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.29 |
| Interest Coverage | -21.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.70% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.13M |
| Profits Per Employee | -121,879 |
| Employee Count | 1,657 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -45.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.77% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +9.77% |
| 50-Day Moving Average | 311.98 |
| 200-Day Moving Average | 298.52 |
| Relative Strength Index (RSI) | 46.35 |
| Average Volume (20 Days) | 257 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533259 had revenue of INR 15.13 billion and -201.95 million in losses. Loss per share was -6.36.
| Revenue | 15.13B |
| Gross Profit | 622.01M |
| Operating Income | -281.53M |
| Pretax Income | -305.69M |
| Net Income | -201.95M |
| EBITDA | -212.50M |
| EBIT | -281.53M |
| Loss Per Share | -6.36 |
Balance Sheet
The company has 302.16 million in cash and 256.57 million in debt, with a net cash position of 45.60 million.
| Cash & Cash Equivalents | 302.16M |
| Total Debt | 256.57M |
| Net Cash | 45.60M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.65B |
| Book Value Per Share | 201.37 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -738.30 million and capital expenditures -149.32 million, giving a free cash flow of -887.61 million.
| Operating Cash Flow | -738.30M |
| Capital Expenditures | -149.32M |
| Depreciation & Amortization | 69.03M |
| Net Borrowing | 210.36M |
| Free Cash Flow | -887.61M |
| FCF Per Share | n/a |
Margins
Gross margin is 4.11%, with operating and profit margins of -1.86% and -1.33%.
| Gross Margin | 4.11% |
| Operating Margin | -1.86% |
| Pretax Margin | -2.02% |
| Profit Margin | -1.33% |
| EBITDA Margin | -1.40% |
| EBIT Margin | -1.86% |
| FCF Margin | n/a |
Dividends & Yields
BOM:533259 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | -2.11% |
| FCF Yield | -9.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |